as 04-01-2025 4:00pm EST
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.
Founded: | 2014 | Country: | United States |
Employees: | N/A | City: | SAN DIEGO |
Market Cap: | 22.3M | IPO Year: | N/A |
Target Price: | $15.00 | AVG Volume (30 days): | 433.2K |
Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -5.51 | EPS Growth: | N/A |
52 Week Low/High: | $0.54 - $8.30 | Next Earning Date: | 05-13-2025 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
CLDI Breaking Stock News: Dive into CLDI Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
GlobeNewswire
a day ago
GlobeNewswire
4 days ago
GlobeNewswire
6 days ago
ACCESS Newswire
18 days ago
NewMediaWire
21 days ago
GlobeNewswire
22 days ago
ACCESS Newswire
a month ago
The information presented on this page, "CLDI Calidi Biotherapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.